Fibrinolysin, antagonists & inhibitors
DBCAT003019Pharmacologic class
A DrugBank category of 2 drugs.
What you can answer from here — as of November 14, 2016
Which targets do Fibrinolysin, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account